Funding Mechanisms Affect Research Culture

Photo: Paul Smaglik Research equipment spills into the hallway of NIH's Clinical Research Center (Building 10). While an addition to that building is scheduled for completion in 2002, some NIH campus scientists wonder whether construction alone can contain the burgeoning intramural research program. Freezers, centrifuges, and tanks crowd the corridors of the National Institutes of Health's Clinical Research Center (Building 10). In one of that building's shared lab rooms, benches li

Written byPaul Smaglik
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Mike Lenardo, NIAID molecular immunologist, notes that the crowded conditions are highly variable. "It depends on what institute you're at and what sort of research you're doing," he comments. He adds that an upside to the lack of space exists--scientists are in frequent contact with one another. "I think having one person per room would be a disaster," Lenardo notes. "Good science requires constant communication."

However, Stephen Marx, National Institute of Diabetes and Digestive and Kidney Diseases researcher, thinks there is such a thing as too much closeness at the NIH's laboratory--especially inside Building 10. "Things are very tight," he notes. "If we had more space, we could do more work." Still, Marx sees an upside of sorts in the situation. He notes that he would likely inherit ample lab space should he choose to go to academia. But that space would be accompanied by higher personnel uncertainty than he's ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies